Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024

  1. Immuneering Corp

    World Rank (Jan-05-2024)
    17,967
    Market Cap (Jan-05-2024)
    0.198 Billion USD
    World Rank (Jul-30-2023)
    15,921
    Market Cap (Jul-30-2023)
    0.296 Billion USD
    World Rank (Dec-25-2022)
    20,921
    Market Cap (Dec-25-2022)
    0.115 Billion USD
    World Rank (Jan-07-2022)
    14,690
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Headquarters Country
    Company Profile
    Biopharmaceutical company with headquarters is in USA.
  2. MacroGenics Inc.

    World Rank (Jan-05-2024)
    11,264
    Market Cap (Jan-05-2024)
    0.623 Billion USD
    World Rank (Jul-30-2023)
    16,045
    Market Cap (Jul-30-2023)
    0.289 Billion USD
    World Rank (Dec-25-2022)
    14,480
    Market Cap (Dec-25-2022)
    0.365 Billion USD
    World Rank (Jan-07-2022)
    9,924
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -202 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    MacroGenics is a Clinical Stage Biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody based therapeutics for the treatment of cancer. The company annual revenue is 64 million USD and  307 employees as on 2019. The headquarters is in USA.
  3. Vigil Neuroscience Inc.

    World Rank (Jan-05-2024)
    20,457
    Market Cap (Jan-05-2024)
    0.121 Billion USD
    World Rank (Jul-30-2023)
    16,087
    Market Cap (Jul-30-2023)
    0.287 Billion USD
    World Rank (Dec-25-2022)
    13,902
    Market Cap (Dec-25-2022)
    0.399 Billion USD
    Headquarters Country
    Company Profile
    Vigil Neuroscience Inc is a microglia-focused company dedicated to improving the lives of patients, caregivers and families affected by rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain’s immune system. The headquarters is in United States.
  4. X4 Pharmaceuticals

    World Rank (Jan-05-2024)
    19,766
    Market Cap (Jan-05-2024)
    0.139 Billion USD
    World Rank (Jul-30-2023)
    16,101
    Market Cap (Jul-30-2023)
    0.287 Billion USD
    World Rank (Dec-25-2022)
    21,362
    Market Cap (Dec-25-2022)
    0.105 Billion USD
    World Rank (Jan-07-2022)
    25,469
    Market Cap (Jan-07-2022)
    0.06 Billion USD
    Headquarters Country
  5. Talkspace Inc.

    World Rank (Jan-05-2024)
    14,117
    Market Cap (Jan-05-2024)
    0.391 Billion USD
    World Rank (Jul-30-2023)
    16,127
    Market Cap (Jul-30-2023)
    0.286 Billion USD
    World Rank (Dec-25-2022)
    21,535
    Market Cap (Dec-25-2022)
    0.102 Billion USD
    World Rank (Jan-07-2022)
    16,822
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Headquarters Country
  6. Omeros Corporation

    World Rank (Jan-05-2024)
    18,164
    Market Cap (Jan-05-2024)
    0.190 Billion USD
    World Rank (Jul-30-2023)
    16,148
    Market Cap (Jul-30-2023)
    0.285 Billion USD
    World Rank (Dec-25-2022)
    19,264
    Market Cap (Dec-25-2022)
    0.159 Billion USD
    World Rank (Jan-07-2022)
    15,000
    Market Cap (Jan-07-2022)
    0.39 Billion USD
    Annual Revenue in USD
    74 Million USD
    Annual Net Income in USD
    -138 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Omeros is a Pharmaceutical Industry through novel discovery, strategic translational research and vigorous clinical programs. The company annual revenue is 13.5 million USD, total assets is 136.9 million USD and 265 employees as on 2020. The headquarters is in USA.
  7. Atea Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    16,476
    Market Cap (Jan-05-2024)
    0.264 Billion USD
    World Rank (Jul-30-2023)
    16,155
    Market Cap (Jul-30-2023)
    0.284 Billion USD
    World Rank (Dec-25-2022)
    14,183
    Market Cap (Dec-25-2022)
    0.382 Billion USD
    World Rank (Jan-07-2022)
    11,890
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    351 Million USD
    Annual Net Income in USD
    121 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Atea is a Clinical Stage Biopharmaceutical company. It is focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life threatening viral diseases. The company annual revenue is 13.6 million USD and 6,904 employees as on 2019. The headquarters is in USA.
  8. Stoke Therapeutics

    World Rank (Jan-05-2024)
    16,842
    Market Cap (Jan-05-2024)
    0.245 Billion USD
    World Rank (Jul-30-2023)
    16,233
    Market Cap (Jul-30-2023)
    0.280 Billion USD
    World Rank (Dec-25-2022)
    15,180
    Market Cap (Dec-25-2022)
    0.327 Billion USD
    World Rank (Jan-07-2022)
    11,113
    Market Cap (Jan-07-2022)
    0.74 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -85 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Stoke Therapeutics is a Biotechnology company. The company estimated annual revenue is currently 7.9 million USD per year and has 44 employees as on 2019. The headquarters is in USA.
  9. BioXcel Therapeutics Inc.

    World Rank (Jan-05-2024)
    22,425
    Market Cap (Jan-05-2024)
    0.082 Billion USD
    World Rank (Jul-30-2023)
    16,250
    Market Cap (Jul-30-2023)
    0.279 Billion USD
    World Rank (Dec-25-2022)
    11,117
    Market Cap (Dec-25-2022)
    0.616 Billion USD
    World Rank (Jan-07-2022)
    12,830
    Market Cap (Jan-07-2022)
    0.55 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -106 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    BioXcel Therapeutics is a clinical Stage Biopharmaceutical company utilizing artificial intelligence or AI to identify improved therapies in neuroscience and immuno oncology. The headquarters is in USA.

Share

Ads